These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11083368)

  • 1. Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis.
    Wolthers OD
    Acta Paediatr; 2000 Oct; 89(10):1158-61. PubMed ID: 11083368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
    Skoner DP; Gentile D; Angelini B; Kane R; Birdsall D; Banerji D
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.
    Gulliver T; Eid N
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis.
    Blaiss MS
    Allergy Asthma Proc; 2007; 28(2):145-52. PubMed ID: 17479597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids: clinical relevance of safety measures.
    Price JF
    Pediatr Pulmonol Suppl; 1997 Sep; 15():40-5. PubMed ID: 9316101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal triamcinolone and growth velocity.
    Skoner DP; Berger WE; Gawchik SM; Akbary A; Qiu C
    Pediatrics; 2015 Feb; 135(2):e348-56. PubMed ID: 25624374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis.
    Möller C; Ahlström H; Henricson KA; Malmqvist LA; Akerlund A; Hildebrand H
    Clin Exp Allergy; 2003 Jun; 33(6):816-22. PubMed ID: 12801318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased risk of adrenal cortex failure after treatment of allergic rhinitis].
    Rolandsson O
    Lakartidningen; 1996 Jul; 93(28-29):2564. PubMed ID: 8801405
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of intranasal corticosteroids in the management of pediatric allergic rhinitis.
    Kaari J
    Clin Pediatr (Phila); 2006 Oct; 45(8):697-704. PubMed ID: 16968954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic doses of glucocorticoids: implications for oral medicine.
    Baid SK; Nieman LK
    Oral Dis; 2006 Sep; 12(5):436-42. PubMed ID: 16910913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children.
    Boner AL
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S32-9. PubMed ID: 11449204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of the newer inhaled corticosteroids in childhood asthma.
    Randell TL; Donaghue KC; Ambler GR; Cowell CT; Fitzgerald DA; van Asperen PP
    Paediatr Drugs; 2003; 5(7):481-504. PubMed ID: 12837120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications.
    Wolthers OD; Honour JW
    J Asthma; 1999 Sep; 36(6):477-86. PubMed ID: 10498042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-vasopressin in the evaluation of the hypothalamic-pituitary-adrenal axis in children with allergic rhinitis treated with intranasal beclomethasone dipropionate or oral prednisone.
    Kokron CM; Castro AS; Solé D; Naspitz CK
    J Investig Allergol Clin Immunol; 1997; 7(1):51-6. PubMed ID: 9093935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
    Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.
    Lipworth BJ; Seckl JR
    Thorax; 1997 May; 52(5):476-82. PubMed ID: 9176542
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis.
    Manji J; Singh G; Okpaleke C; Dadgostar A; Al-Asousi F; Amanian A; Macias-Valle L; Finkelstein A; Tacey M; Thamboo A; Javer A
    Int Forum Allergy Rhinol; 2017 May; 7(5):488-493. PubMed ID: 28151588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis.
    Hampel FC; Nayak NA; Segall N; Small CJ; Li J; Tantry SK
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):137-42. PubMed ID: 26250771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special problems in glucocorticoid treatment in children.
    Wahn U
    Ernst Schering Res Found Workshop; 2002; (40):83-90. PubMed ID: 12355730
    [No Abstract]   [Full Text] [Related]  

  • 20. Beclomethasone dipropionate in the management of rhinitis--a review.
    Small P; Black M; Frenkiel S; Wachs GN
    Ann Allergy; 1982 Sep; 49(3):127-30. PubMed ID: 7051907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.